These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 19778224)

  • 1. Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI-6.
    Lorke DE; Hasan MY; Nurulain SM; Kuca K; Schmitt A; Petroianu GA
    Toxicol Mech Methods; 2009 May; 19(4):327-33. PubMed ID: 19778224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five oximes (K-27, K-48, obidoxime, HI-6 and trimedoxime) in comparison with pralidoxime: survival in rats exposed to methyl-paraoxon.
    Petroianu GA; Nurulain SM; Nagelkerke N; Shafiullah M; Kassa J; Kuca K
    J Appl Toxicol; 2007; 27(5):453-7. PubMed ID: 17304644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eight new bispyridinium oximes in comparison with the conventional oximes pralidoxime and obidoxime: in vivo efficacy to protect from diisopropylfluorophosphate toxicity.
    Lorke DE; Nurulain SM; Hasan MY; Kuca K; Musilek K; Petroianu GA
    J Appl Toxicol; 2008 Oct; 28(7):920-8. PubMed ID: 18548743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments on "Efficacy of two new asymmetric bispyridinium oximes (K-27 and K-48) in rats exposed to diisopropylfluorophosphate: comparison with pralidoxime, obidoxime, trimedoxime, methoxime, and HI 6".
    Theirmann H; Worek F; Eyer P
    Toxicol Mech Methods; 2009 May; 19(4):334; author reply 335. PubMed ID: 19778225
    [No Abstract]   [Full Text] [Related]  

  • 5. A comparison of the efficacy of a bispyridinium oxime--1,4-bis-(2-hydroxyiminomethylpyridinium) butane dibromide and currently used oximes to reactivate sarin, tabun or cyclosarin-inhibited acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J
    Pharmazie; 2004 Oct; 59(10):795-8. PubMed ID: 15544060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro potency of H oximes (HI-6, HLö-7), the oxime BI-6, and currently used oximes (pralidoxime, obidoxime, trimedoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinova M
    J Toxicol Environ Health A; 2006 Aug; 69(15):1431-40. PubMed ID: 16766478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the reactivating and therapeutic efficacy of newly developed bispyridinium oximes (K250, K251) with commonly used oximes against tabun in rats and mice.
    Kassa J; Karasova J; Bajgar J; Kuca K; Musilek K; Kopelikova I
    J Enzyme Inhib Med Chem; 2009 Aug; 24(4):1040-4. PubMed ID: 19552519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova J; Musilek K; Kuca K
    Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro effects of acetylcholinesterase reactivators on monoamine oxidase activity.
    Fišar Z; Hroudová J; Korábečný J; Musílek K; Kuča K
    Toxicol Lett; 2011 Mar; 201(2):176-80. PubMed ID: 21195145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of reactivating and therapeutic efficacy of the oxime K203 and its fluorinated analog (KR-22836) with currently available oximes (obidoxime, trimedoxime, HI-6) against tabun in rats and mice.
    Kassa J; Karasova JZ; Caisberger F; Musilek K; Kuca K; Jung YS
    J Enzyme Inhib Med Chem; 2010 Aug; 25(4):480-4. PubMed ID: 20233085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of reactivating and therapeutic efficacy of bispyridinium acetylcholinesterase reactivator KR-22934 with the oxime K203 and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
    Kassa J; Karasova JZ; Pavlikova R; Musilek K; Kuca K; Bajgar J; Jung YS
    Toxicol Mech Methods; 2011 Mar; 21(3):241-5. PubMed ID: 21142778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of eight experimental bispyridinium oximes against paraoxon-induced mortality: comparison with the conventional oximes pralidoxime and obidoxime.
    Nurulain SM; Lorke DE; Hasan MY; Shafiullah M; Kuca K; Musilek K; Petroianu GA
    Neurotox Res; 2009 Jul; 16(1):60-7. PubMed ID: 19526299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: survival in rats exposed to the organophosphate paraoxon.
    Petroianu GA; Nurulain SM; Nagelkerke N; Al-Sultan MA; Kuca K; Kassa J
    J Appl Toxicol; 2006; 26(3):262-8. PubMed ID: 16583462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro oxime reactivation of red blood cell acetylcholinesterase inhibited by methyl-paraoxon.
    Petroianu GA; Arafat K; Nurulain SM; Kuca K; Kassa J
    J Appl Toxicol; 2007; 27(2):168-75. PubMed ID: 17265452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five oximes (K-27, K-33, K-48, BI-6 and methoxime) in comparison with pralidoxime: in vitro reactivation of red blood cell acetylcholinesterase inhibited by paraoxon.
    Petroianu GA; Arafat K; Kuca K; Kassa J
    J Appl Toxicol; 2006; 26(1):64-71. PubMed ID: 16193529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the reactivating effect of BI-6, a new asymmetrical bispyridinium oxime, with oxime HI-6 and obidoxime on soman-inhibited acetylcholinesterase in the diaphragm and various parts of the brain in rats].
    Kassa J; Bajgar J
    Cas Lek Cesk; 1999 Aug; 138(17):532-5. PubMed ID: 10566233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of in vitro potency of oximes (pralidoxime, obidoxime, HI-6) to reactivate sarin-inhibited acetylcholinesterase in various parts of pig brain.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
    J Appl Toxicol; 2005; 25(4):271-6. PubMed ID: 16021679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro oxime protection of human red blood cell acetylcholinesterase inhibited by diisopropyl-fluorophosphate.
    Lorke DE; Hasan MY; Arafat K; Kuca K; Musilek K; Schmitt A; Petroianu GA
    J Appl Toxicol; 2008 May; 28(4):422-9. PubMed ID: 18344198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
    Kuca K; Cabal J
    Cent Eur J Public Health; 2004 Mar; 12 Suppl():S59-61. PubMed ID: 15141981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the potency of the oxime HLö-7 and currently used oximes (HI-6, pralidoxime, obidoxime) to reactivate nerve agent-inhibited rat brain acetylcholinesterase by in vitro methods.
    Kuca K; Cabal J; Kassa J; Jun D; Hrabinová M
    Acta Medica (Hradec Kralove); 2005; 48(2):81-6. PubMed ID: 16259317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.